Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 153 Records) |
| Query Trace: Pancreatic Neoplasms and KRAS[original query] |
|---|
| Mutation Analysis of Pancreatic Juice and Plasma for the Detection of Pancreatic Cancer. International journal of molecular sciences 2023 9 24 (17): . Iris J M Levink, Maurice P H M Jansen, Zakia Azmani, Wilfred van IJcken, Ronald van Marion, Maikel P Peppelenbosch, Djuna L Cahen, Gwenny M Fuhler, Marco J Bru |
| KRAS mutations in pancreatic cancer: could we talk about a risk factor for the development of thromboembolic phenomena? Revista espanola de enfermedades digestivas 2023 9 . César Gutiérrez Pérez, Carmen Blanco Abad, Gadea Hontoria Bautista, Patricia Saiz López, Inmaculada Rodríguez Ledesma, Noelia Espinosa Cabria, Irene Ramos Reguera, Ana María López Muñ |
| KRAS Wild-type Pancreatic Cancer: Decoding Genomics, Unlocking Therapeutic Potential. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 9 . Hiroyuki Kato, Haley Ellis, Nabeel Bardee |
| The Mutation Portraits of Oncogenes and Tumor Supressor Genes in Predicting the Overall Survival in Pancreatic Cancer: A Bayesian Network Meta-Analysis. Asian Pacific journal of cancer prevention : APJCP 2023 8 24 (8): 2895-2902. Citra Aryanti, Julianus Aboyaman Uwuratuw, Ibrahim Labeda, Warsinggih Raharjo, Ronald Erasio Lusikooy, Murny Abdul Rauf, Andi Mappincara, Samuel Sampetoding, M Ihwan Kusuma, Erwin Syarifudd |
| Targeting KRAS Mutations: Discovery of Small Molecule Inhibitors for the Potential Treatment of Intractable Cancers. ACS medicinal chemistry letters 2023 8 14 (8): 1041-1042. Robert B Karg |
| Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 7 . Harshabad Singh, Rachel B Keller, Kevin S Kapner, Julien Dilly, Srivatsan Raghavan, Chen Yuan, Elizabeth F Cohen, Michael Tolstorukov, Elizabeth Andrews, Lauren K Brais, Annacarolina da Silva, Kimberly Perez, Douglas A Rubinson, Rishi Surana, Marios Giannakis, Kimmie Ng, Thomas E Clancy, Matthew B Yurgelun, Benjamin L Schlechter, Jeffrey W Clark, Geoffrey I Shapiro, Michael H Rosenthal, Jason L Hornick, Valentina Nardi, Yvonne Y Li, Hersh Gupta, Andrew D Cherniack, Matthew Meyerson, James M Cleary, Jonathan A Nowak, Brian M Wolpin, Andrew J Aguir |
| Genomic landscape of pancreatic cancer in the Japanese version of the Cancer Genome Atlas. Annals of gastroenterological surgery 2023 5 7 (3): 491-502. Taisuke Imamura, Ryo Ashida, Keiichi Ohshima, Katsuhiko Uesaka, Teiichi Sugiura, Yukiyasu Okamura, Katsuhisa Ohgi, Sumiko Ohnami, Takeshi Nagashima, Ken Yamaguc |
| Analysis of Plasma Circulating Tumor DNA in Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration Detection. Cancer research and treatment 2023 5 . Dong-Hoon Lim, Hyunseok Yoon, Kyu-Pyo Kim, Baek-Yeol Ryoo, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dae Wook Hwang, Jae Hoon Lee, Ki Byung Song, Song Cheol Kim, Seung-Mo Hong, Jaewon Hyung, Changhoon Y |
| Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan. Journal of gastroenterology 2023 4 . Sakakida Tomoki, Ishikawa Takeshi, Doi Toshifumi, Morita Ryuichi, Kataoka Seita, Miyake Hayato, Yamaguchi Kanji, Moriguchi Michihisa, Sogame Yoshio, Yasuda Hiroaki, Iwasaku Masahiro, Konishi Hideyuki, Takayama Koichi, Itoh Yoshi |
| Advanced pancreatic cancer with KRAS wild-type and EGFR-sensitive mutation respond favorably to furmonertinib: A case report. Frontiers in oncology 2023 4 13 1151178. Xiaoting Ma, Xiu Liu, Kai Ou, Manman Zhang, Lizhen Gao, Lin Ya |
| Molecular characteristics of early-onset pancreatic ductal adenocarcinoma. Molecular oncology 2023 12 . Silvana Debernardi, Lukasz Liszka, Chara Ntala, Katja Steiger, Irene Esposito, Emanuela Carlotti, Ann-Marie Baker, Stuart McDonald, Trevor Graham, Branko Dmitrovic, Roger M Feakins, Tatjana Crnogorac-Jurcev |
| Single-Cell Analysis Differentiates the Effects of p53 Mutation and p53 Loss on Cell Compositions of Oncogenic Kras-Driven Pancreatic Cancer. Cells 2023 11 12 (22): . Xinlei Sun, Daowei Yang, Yang Ch |
| Loss of p53 and SMAD4 induces adenosquamous subtype pancreatic cancer in the absence of an oncogenic KRAS mutation. Cell reports. Medicine 2024 9 101711. Daowei Yang, Xinlei Sun, Rohan Moniruzzaman, Hua Wang, Citu Citu, Zhongming Zhao, Ignacio I Wistuba, Huamin Wang, Anirban Maitra, Yang Ch |
| Prevalence of KRAS amplification in patients with metastatic cancer: Real-world next-generation sequencing analysis. Pathology, research and practice 2024 8 261 155473. Dae-Ho Choi, Hye-Lim Jang, Sung Hee Lim, Seung Tae Kim, Jung Yong Hong, Se Hoon Park, Joon Oh Park, Deok Geun Kim, Kyoung-Mee Kim, Jeeyun L |
| Alterations in genes involved in glycolysis and hypoxia affect the prognosis of pancreatic cancer. Heliyon 2024 8 10 (14): e34104. Yujie Huang, Qilu Zhu, Yizhang Sun, Weigang Zhang, Jiayue Z |
| Clinical and molecular features of early onset pancreatic adenocarcinoma. International journal of cancer 2024 8 . Maxime Rémond, Cristina Smolenschi, Anthony Tarabay, Maximiliano Gelli, Elena Fernandez-de-Sevilla, Ali Mouawia, Simona Cosconea, Lambros Tselikas, Remy Barbe, Alina Fuerea, Mohamed A Bani, Marc Deloger, Benjamin Besse, Thomas Pudlarz, Marine Valéry, Valérie Boige, Antoine Hollebecque, Michel Ducreux, Alice Boilè |
| Sotorasib as Fourth-Line Treatment in Pancreatic Cancer: A Case Report and Literature Review. Rhode Island medical journal (2013) 2024 6 107 (7): 10-13. Ifeanyi David Onukogu, Georgio Medawar, Yashvin Onkarappa Mangala, Ritesh Ratho |
| Correction to: Application of plasma circulating KRAS mutations as a predictive biomarker for targeted treatment of pancreatic cancer. Cancer science 2024 5 . Authors are not available |
| Precision medicine for pancreatic cancer: Characterizing the clinico-genomic landscape and outcomes of KRAS G12C-mutated disease. Journal of the National Cancer Institute 2024 5 . Fergus Keane, Joanne F Chou, Henry Walch, Joshua Schoenfeld, Anupriya Singhal, Darren Cowzer, Emily Harrold, Catherine O'Connor, Wungki Park, Anna Varghese, Imane El Dika, Fiyinfolu Balogun, Kenneth H Yu, Marinela Capanu, Nikolaus Schultz, Rona Yaeger, Eileen M O'Reil |
| The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study. Cancers 2024 5 16 (9): . Mark Ayoub, Carol Faris, Tajana Juranovic, Harleen Chela, Ebubekir Daglil |
| Analysis of Methylation of Tumor-suppressive miRNAs and KRAS/TP53 Mutations in Pancreatic Juice. Anticancer research 2024 12 44 (12): 5253-5261. Koushiro Ohtsubo, Kunio Miyake, Shigeki Sato, Hiroyuki Sakaguchi, Koji Fukuda, Hiroshi Kotani, Akihiro Nishiyama, Shigeki Nanjo, Kaname Yamashita, Shinji Takeuchi, Seiji Yano, Sawako Kuruma, Jun Nakahodo, Masataka Kikuyama, Hiroaki Taniguc |
| Molecular Characterization and Clinical Relevance of MGMT-Silenced Pancreatic Cancer. Cancer medicine 2024 12 13 (23): e70393. Federico Nichetti, Marco Silvestri, Luca Agnelli, Andrea Franza, Chiara Pircher, Simone Rota, Paolo Ambrosini, Giuseppe Fotia, Jennifer Hüllein, Giovanni Randon, Panna Lajer, Federica Perrone, Elena Tamborini, Giuseppe Leoncini, Jorgelina Coppa, Michele Droz Dit Busset, Sara Pusceddu, Massimo Milione, Federica Morano, Filippo Pietrantonio, Giancarlo Pruneri, Vincenzo Mazzaferro, Daniel B Lipka, Bruno Christian Köhler, Daniel Hübschmann, Stefan Fröhling, Filippo de Braud, Monica Nig |
| [A real-world study of first-line albumin-bound paclitaxel in the treatment of advanced pancreatic cancer in China]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2024 12 46 (11): 1038-1048. J Du, X Qiu, J Y Ni, Q L Wang, F Tong, H Z Sha, Y H Zhu, L Qi, W Cai, C Gao, X W Wei, M B Chen, Z Y Qian, M H Cai, M Tao, C L Wang, G C Zheng, H Jiang, A W Dai, J Wu, M H Zhao, X Q Li, B Lu, C B Wang, B R L |
| [Molecular pathology of gastrointestinal neoplasms]. Magyar onkologia 2024 12 68 (4): 325. Tamás Strausz, László Báthory-Fülöp, Eszter Papp, Erika Tó |
| Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre study. EBioMedicine 2024 10 109 105373. Rémy Nicolle, Cindy Canivet, Laurent Palazzo, Bertrand Napoléon, Mira Ayadi, Camille Pignolet, Jérôme Cros, Sophie Gourgou, Janick Selves, Jérôme Torrisani, Nelson Dusetti, Pierre Cordelier, Louis Buscail, Barbara Bournet, |
| Mutant KRAS in Circulating Tumor DNA as a Biomarker in Localized Pancreatic Cancer in Patients Treated with Neoadjuvant Chemotherapy. Annals of surgery 2024 10 . Dominic J Vitello, Dhavan Shah, Amy Wells, Larissa Masnyk, Madison Cox, Lauren M Janczewski, John Abad, Kevin Dawravoo, Arlene D'Souza, Grace Suh, Robert Bayer, Massimo Cristofanilli, David Bentrem, Yingzhe Liu, Hui Zhang, Lucas Santana-Santos, Lawrence J Jennings, Qiang Zhang, Akhil Chaw |
| Prognostic Role of Specific KRAS Mutations Detected in Aspiration and Liquid Biopsies from Patients with Pancreatic Cancer. Genes 2024 10 15 (10): . Tereza Hálková, Bohuš Bungani?, Eva Traboulsi, Marek Minárik, Miroslav Zavoral, Lucie Benešo |
| Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123). Journal of cancer research and clinical oncology 2024 10 150 (10): 438. David Witte, Ina Pretzell, Timm M Reissig, Alexander Stein, Janna-Lisa Velthaus, Annabel Alig, Hanibal Bohnenberger, Maren Knödler, Annika Kurreck, Sabrina Sulzer, Georg Beyer, Klara Dorman, Tabea Fröhlich, Stefanie Hegenberg, Celine Lugnier, Anna Saborowski, Arndt Vogel, Sebastian Lange, Maximilian Reichert, Franziska Flade, Lioba Klaas, Kirsten Utpatel, Heiko Becker, Annalen Bleckmann, Klaus Wethmar, Anke Reinacher-Schick, Christoph Benedikt Westphal |
| Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic cancer. Journal of cancer research and clinical oncology 2024 1 150 (2): 35. Hideki Motobayashi, Yuji Kitahata, Ken-Ichi Okada, Motoki Miyazawa, Masaki Ueno, Shinya Hayami, Atsushi Miyamoto, Atsushi Shimizu, Masatoshi Sato, Tomohiro Yoshimura, Yuki Nakamura, Norio Takemoto, Tomoki Nakai, Takahiko Hyo, Kyohei Matsumoto, Hiroki Yamaue, Manabu Kaw |
| [Mutations and their consequences in the development of pancreatic cancer]. Postepy biochemii 2025 1 70 (4): 490-496. Przemys?aw Panek, Jaros?aw Rachuna, ?ukasz Madej, Ryszard Tomasiuk, Aleksandra Jezela-Stan |
- Page last reviewed:Feb 1, 2024
- Content source: